3Moreau C, Dmi D, Amault-Ouary G, et al, Fulminant type 1 diabetes in Caucasians: A report of three cases [J]. Diabetes Metab, 2008,34(5) :529-532.
4Shimizu I, Makino H, Osawa H, et al. Association of fulminant type 1 diabetes with pregnancy [ J ]. Diabetes Res Clin Pract, 2003,62 ( 1 ) :33-38.
5Eisenbarth GS, et al. Type 1 Diabetes Mellitus. Williams Textbook of Endocrinology [ M]. edn 10. Philadelphia: WB Saunders, 2003 : 1485-1504.
6Imagawa A, Hanafusa T, Makino H, et al. High titles of IgA antibodies to enterovirus in fulminant type-1 diabetes [ J ]. Diabetologia, 2005,48(2) :290-293.
7Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies [J]. N Engl J Med, 2000,342(5) :301- 307.
8Shimizu I, Makino H, Imagawa A, et al. ClinicAl and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy [J]. J Clin Endocrinol Metab, 2006,91(2) :471-476.
9Hanafusa T, Imagawa A. Fulminant typeldiabetes: a novel clincal entity requiring special attention by all medical practitioners [ J ]. Nat Clin Pract Endocrinol Metab, 2007,3( 1 ) :36-45.
10Hiroko T, Yasuko U, Naoko I, et al. Transient elevation of liver transarninase after starting insulin therapy for diabetic ketosis or ketoacidosis in newly diagnosed type 1 diabetes mellitus [J]. Diabetes Res Clin Pract, 2004,64( 1 ) :27-32.
2Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.Diabetes Care.1997,20:1183-1197.
3Tan KC,Mackay IR,Zimmet PZ,et al.Metabolic and immunologic features of Chinese patients with atypical diabetes melltitus.Diabetes Care,2000,23:335-338.
4Pinero-Pilona A,Litonjua P,Aviles-Santa L,et al.Idiopathic type 1 diabetes in Dallas,Texas.A 5-year experience.Diabetes Care,2001,24:1014-1018.
5Tiberti C,Buzzetti R,Anastasi E,et al.Autoantibody negative new onset type 1 diabetes lacking high risk HLA alleles in a Caucasian population :are these type lb diabetes cases? Diabetes Metab Res Rev,2000,16:8-14.
6Sabbah E,Savola K,Ebeling T,et al.Genetic,autoimmune,and clinical characteristics of childhood and adult-onset type 1diabetes.Diabetes Care,2000,23:1326-1332.
7Veijola R,Knip M,Reijonen H,et al.Effect of genetic risk load defined by HLA DQB1 polymorphism on clinical characteristics of IDDM in children.Eur J Clin Invest,1995,25:106-112.
8Imagawa A,Hanafusa T,Miyagawa J,et al.A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies.N Engl J Med,2000,342:301-307.
9Imagawa A,Hanafusa T,Uchigata Y,et al.Fulminant type 1diabetes.A nationwide survey in Japan.Diabetes Care,2003,26:2345-2352.
10Pinero-Pilona A,Litonjua P.Idiopathic type 1 diabetes.J Diabetes Complications,2001,15:328-335.
6Umpierrez G E. Ketosis-prone type 2 diabetes: time to revise the elassifieation of diabetes. Diabetes Care, 2006, 29: 2755- 2757.
7Maldonado M, Hampe C S, Gaur L K, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classit:ication, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab, 2003, 88:5090-5098.
8Myers M A, Rabin D U, Rowley M J. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Diabetes, 1995, 44:1290-1295.
9Maldonado M, Hampe C S, Gaur L K, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes. J Clin Endocrinol Metab, 2003, 88.. 5090-5098.
10Mauvais-Jarvis F, Sobngwi E, Porcher R, et al. Ketosisprone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of betacell dysfunction and insulin resistance. Diabetes, 2004, 53: 645-653.
